# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and raises the price target from $17 to $18.
Core Laboratories (NYSE:CLB) reported quarterly Adj earnings of $0.19 per share which beat the analyst consensus estimate of $0...
B of A Securities analyst Chase Mulvehill maintains Core Laboratories (NYSE:CLB) with a Underperform and lowers the price ta...
Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of pre...
Stifel analyst Stephen Gengaro maintains Core Laboratories (NYSE:CLB) with a Hold and lowers the price target from $21 to $17.
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.19 per share which met the analyst consensus estimate. This is a...
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...